FSD Pharma (FSD Pharma) Price-to-Tangible-Book : 1.61 (As of May. 16, 2024)

View and export this data going back to 2018. Start your Free Trial

What is FSD Pharma Price-to-Tangible-Book?

As of today (2024-05-16), FSD Pharma's share price is $0.322. FSD Pharma's Tangible Book per Share of Dec. 2023 for the quarter that ended in Dec. 2023 was $0.20. Hence, FSD Pharma's Price to Tangible Book Ratio of today is 1.61.

The historical rank and industry rank for FSD Pharma's Price-to-Tangible-Book or its related term are showing as below:

HUGE' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 1.1 Med: 1.89 Max: 7.79
Current: 1.69

During the past 9 years, FSD Pharma's highest Price to Tangible Book Ratio was 7.79. The lowest was 1.10. And the median was 1.89.

HUGE's Price-to-Tangible-Book is ranked better than
66.32% of 867 companies
in the Drug Manufacturers industry
Industry Median: 2.37 vs HUGE: 1.69

A closely related ratio is called PB Ratio. As of today, FSD Pharma's share price is $0.322. FSD Pharma's Book Value per Sharefor the quarter that ended in Dec. 2023 was $0.34. Hence, FSD Pharma's P/B Ratio of today is 0.96.

FSD Pharma Price-to-Tangible-Book Historical Data

The historical data trend for FSD Pharma's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

FSD Pharma Price-to-Tangible-Book Chart

FSD Pharma Annual Data

Trend

Aug15

Aug16

Aug17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Price-to-Tangible-Book

Get a 7-Day Free Trial

2.21

1.31

1.09

1.64

4.60

FSD Pharma Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Price-to-Tangible-Book	Get a 7-Day Free Trial															1.64	5.83	4.49	5.09	4.60

Competitive Comparison of FSD Pharma's Price-to-Tangible-Book

For the Drug Manufacturers - Specialty & Generic subindustry, FSD Pharma's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

FSD Pharma's Price-to-Tangible-Book Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, FSD Pharma's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where FSD Pharma's Price-to-Tangible-Book falls into.

FSD Pharma Price-to-Tangible-Book Calculation

FSD Pharma's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book	=	Share Price	/	Tangible Book per Share (Q: Dec. 2023 )
	=	0.322	/	0.2
	=	1.61

It can also be calculated from the numbers for the whole company:

Price to Tangible Book	=	Market Cap	/	Tangible Equity
	=	Market Cap	/	(Total Stockholders Equity	-	Preferred Stock	-	Intangible Assets)

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.

FSD Pharma Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of FSD Pharma's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.

FSD Pharma (FSD Pharma) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » FSD Pharma Inc (NAS:HUGE) » Definitions » Price-to-Tangible-Book

Comparable Companies

Traded in Other Exchanges

0K9:Germany HUGE:Canada

Address

199 Bay Street, Suite 4000, Toronto, ON, CAN, M5L 1A9

Website

https://www.fsdpharma.com

FSD Pharma Inc is a biopharmaceutical company developing three clinical candidates with the potential to address neuropsychiatric, neurodegenerative, and inflammatory disorders. Along with its subsidiaries, the group is focused on pharmaceutical research and development of its compound, FSD201, an ultra-micronized PEA, for the treatment of inflammatory diseases; Lucid-Psych is used in the treatment of mental health disorders and Lucid-MS is used in the treatment of neurodegenerative disorders. The Company operates in two segments: Biotechnology and Strategic Investments.